BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 32036390)

  • 1. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice.
    Zhou Z; Ni J; Li J; Huo C; Miao N; Yin F; Cheng Q; Xu D; Xie H; Chen P; Zheng P; Zhang Y; Zhou L; Zhang W; Yu C; Liu J; Lu L
    J Mol Med (Berl); 2020 Apr; 98(4):527-540. PubMed ID: 32036390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling.
    Shen Y; Miao N; Wang B; Xu J; Gan X; Xu D; Zhou L; Xue H; Zhang W; Yang L; Lu L
    Kidney Int; 2017 Oct; 92(4):888-899. PubMed ID: 28483378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of Gadd45β ameliorates the inflammation and renal fibrosis caused by unilateral ureteral obstruction.
    Moon SJ; Kim JH; Choi YK; Lee CH; Hwang JH
    J Cell Mol Med; 2020 Aug; 24(15):8814-8825. PubMed ID: 32570293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.
    Park JH; Jang KM; An HJ; Kim JY; Gwon MG; Gu H; Park B; Park KK
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
    Qi FH; Cai PP; Liu X; Si GM
    Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis.
    Sun B; Wang H; Zhang L; Yang X; Zhang M; Zhu X; Ji X; Wang H
    Cytokine; 2018 Jun; 106():80-88. PubMed ID: 29111086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1
    Lemos DR; McMurdo M; Karaca G; Wilflingseder J; Leaf IA; Gupta N; Miyoshi T; Susa K; Johnson BG; Soliman K; Wang G; Morizane R; Bonventre JV; Duffield JS
    J Am Soc Nephrol; 2018 Jun; 29(6):1690-1705. PubMed ID: 29739813
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
    Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
    Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction.
    Gairola S; Ram C; Syed AM; Doye P; Kulhari U; Mugale MN; Murty US; Sahu BD
    Eur J Pharmacol; 2021 Nov; 910():174479. PubMed ID: 34480883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
    Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
    Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1.
    Miao NJ; Xie HY; Xu D; Yin JY; Wang YZ; Wang B; Yin F; Zhou ZL; Cheng Q; Chen PP; Zhou L; Xue H; Zhang W; Wang XX; Liu J; Lu LM
    Acta Pharmacol Sin; 2019 Jun; 40(6):790-800. PubMed ID: 30382182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
    Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
    FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways.
    Weng CH; Li YJ; Wu HH; Liu SH; Hsu HH; Chen YC; Yang CW; Chu PH; Tian YC
    Biomed Pharmacother; 2020 Mar; 123():109741. PubMed ID: 31901549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine attenuates UUO-induced renal fibrosis via TGF-β/Smad and NF-κB signaling.
    Chen J; Li D
    Int Immunopharmacol; 2018 Feb; 55():1-8. PubMed ID: 29207359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ß and Smad3 expression on unilateral ureteral obstruction rat model.
    Kim TW; Kim YJ; Seo CS; Kim HT; Park SR; Lee MY; Jung JY
    Phytomedicine; 2016 Apr; 23(4):331-9. PubMed ID: 27002403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
    Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
    Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease.
    Perretta-Tejedor N; Muñoz-Félix JM; Düwel A; Quiros-Luis Y; Fernández-Martín JL; Morales AI; López-Hernández FJ; López-Novoa JM; Martínez-Salgado C
    Acta Physiol (Oxf); 2019 Jun; 226(2):e13247. PubMed ID: 30589223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzyme USP11 promotes renal tubular cell senescence and fibrosis via inhibiting the ubiquitin degradation of TGF-β receptor II.
    Ni JY; Wang X; Xie HY; Yang NH; Li JY; Sun XA; Guo HJ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2023 Mar; 44(3):584-595. PubMed ID: 36045219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.